仟源医药
(300254)
| 流通市值：23.57亿 | | | 总市值：25.80亿 |
| 流通股本：2.27亿 | | | 总股本：2.48亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 92,408,396.19 | 87,019,428.74 | 149,518,040.96 | 176,478,322.01 |
| 应收票据及应收账款 | 132,674,931.36 | 131,379,941.88 | 148,483,023.02 | 118,889,577.34 |
| 应收账款 | 132,674,931.36 | 131,379,941.88 | 148,483,023.02 | 118,889,577.34 |
| 应收款项融资 | 34,291,766.27 | 32,102,324.85 | 28,217,773.52 | 14,487,760.54 |
| 预付款项 | 2,783,346.44 | 6,090,285.92 | 2,857,050.46 | 8,972,115.03 |
| 其他应收款合计 | 17,976,350.47 | 23,964,386.72 | 17,623,404.03 | 20,997,148.34 |
| 存货 | 149,943,038.52 | 145,675,205.27 | 132,785,588.91 | 116,577,996.45 |
| 其他流动资产 | 26,299,550.35 | 21,138,937.08 | 21,383,452.88 | 23,065,315.48 |
| 流动资产合计 | 456,377,379.6 | 447,370,510.46 | 500,868,333.78 | 479,468,235.19 |
| 非流动资产: | | | | |
| 长期股权投资 | 101,188,402.79 | 101,159,348.3 | 101,188,453.77 | 101,693,547.37 |
| 投资性房地产 | 68,364,983.95 | 68,899,969.06 | 69,434,954.29 | 69,969,939.41 |
| 固定资产 | 244,366,804.5 | 250,304,492.09 | 258,539,976.71 | 260,849,735.73 |
| 在建工程 | 32,893,176.54 | 18,692,672.63 | 15,283,785.93 | 5,523,563.49 |
| 使用权资产 | 29,004,253.94 | 30,867,939.27 | 32,731,624.52 | 26,680,512.08 |
| 无形资产 | 177,446,599.82 | 181,829,026.97 | 188,050,223.56 | 183,489,359.27 |
| 开发支出 | 26,725,892.79 | 23,344,175.65 | 20,059,792.26 | 30,113,457.64 |
| 商誉 | 311,990,498.64 | 311,990,498.64 | 311,990,498.64 | 316,254,442.45 |
| 长期待摊费用 | 3,755,075.17 | 3,732,516.81 | 3,988,444.32 | 3,902,318.45 |
| 递延所得税资产 | 24,882,974.26 | 27,062,447.97 | 27,615,977.58 | 20,047,312.88 |
| 其他非流动资产 | 19,385,199.42 | 18,378,427.48 | 17,973,012.81 | 29,080,580.4 |
| 非流动资产合计 | 1,040,003,861.82 | 1,036,261,514.87 | 1,046,856,744.39 | 1,047,604,769.17 |
| 资产总计 | 1,496,381,241.42 | 1,483,632,025.33 | 1,547,725,078.17 | 1,527,073,004.36 |
| 流动负债: | | | | |
| 短期借款 | 130,919,141.55 | 120,927,525.05 | 127,942,483.93 | 112,905,462.03 |
| 应付票据及应付账款 | 64,965,894.94 | 65,387,314.56 | 52,623,952.73 | 41,899,821.65 |
| 应付账款 | 64,965,894.94 | 65,387,314.56 | 52,623,952.73 | 41,899,821.65 |
| 预收款项 | 370,111.2 | 228,600.7 | 289,055.17 | 529,961.28 |
| 合同负债 | 28,925,367.01 | 12,916,613.72 | 25,664,828.12 | 16,066,634.51 |
| 应付职工薪酬 | 13,148,849.85 | 11,683,313.08 | 24,138,206.08 | 10,188,132.19 |
| 应交税费 | 14,571,515.19 | 16,140,414.98 | 17,217,191.98 | 14,499,631.37 |
| 其他应付款合计 | 83,746,414.44 | 85,589,017.33 | 165,307,278.88 | 92,530,880.96 |
| 一年内到期的非流动负债 | 146,079,066.89 | 148,226,682.5 | 152,473,483.27 | 274,202,244.83 |
| 其他流动负债 | 4,225,808.2 | 5,110,520.53 | 5,149,052.02 | 6,688,978.39 |
| 流动负债合计 | 486,952,169.27 | 466,210,002.45 | 570,805,532.18 | 569,511,747.21 |
| 非流动负债: | | | | |
| 长期借款 | 167,000,000 | 173,300,000 | 153,300,000 | 13,600,000 |
| 租赁负债 | 27,268,332.96 | 28,893,889.04 | 30,320,927.43 | 25,454,593.25 |
| 长期应付款 | 226,336,400 | 226,336,400 | 129,356,400 | - |
| 长期应付职工薪酬 | 3,280,365.08 | 3,580,893.02 | 3,888,129 | 2,656,055.08 |
| 递延收益 | 9,999,282.15 | 10,369,002.98 | 10,787,781.55 | 10,894,774.41 |
| 递延所得税负债 | 43,547,904.32 | 43,996,790.54 | 44,444,596.06 | 45,512,510.49 |
| 其他非流动负债 | 6,821,350.11 | 6,728,331.45 | 6,641,727.87 | 7,052,681.9 |
| 非流动负债合计 | 484,253,634.62 | 493,205,307.03 | 378,739,561.91 | 105,170,615.13 |
| 负债合计 | 971,205,803.89 | 959,415,309.48 | 949,545,094.09 | 674,682,362.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 248,318,563 | 248,318,563 | 248,318,563 | 248,668,563 |
| 资本公积 | 259,793,909.81 | 256,188,505.05 | 349,577,927.94 | 654,775,630.26 |
| 减:库存股 | 31,691,000 | 31,691,000 | 31,691,000 | 33,346,500 |
| 盈余公积 | 17,952,791.16 | 17,952,791.16 | 17,952,791.16 | 17,952,791.16 |
| 未分配利润 | -240,778,530.98 | -230,769,018.87 | -241,159,399.65 | -239,196,263.24 |
| 归属于母公司股东权益合计 | 253,595,732.99 | 259,999,840.34 | 342,998,882.45 | 648,854,221.18 |
| 少数股东权益 | 271,579,704.54 | 264,216,875.51 | 255,181,101.63 | 203,536,420.84 |
| 股东权益合计 | 525,175,437.53 | 524,216,715.85 | 598,179,984.08 | 852,390,642.02 |
| 负债和股东权益合计 | 1,496,381,241.42 | 1,483,632,025.33 | 1,547,725,078.17 | 1,527,073,004.36 |
| 公告日期 | 2025-08-26 | 2025-04-19 | 2025-04-15 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |